SGT-53, a novel nanomedicine that crosses the BBB, augments immunotherapeutic response in pediatric brain cancers

Active Project Grant Awarded Last action

Award ID
HT94252310987
Recipient
Awarding agency
Obligated
$1,528,727

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 91% complete
Originally
Place of performance
Washington, DC 20010, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment Novel nanomedicine that crosses the BBB augments immunotherapeutic response in pediatric brain cancers $0
Original award $1,528,727

Subawards

Subrecipient Amount Awarded
Synergene Therapeutics Inc. s SGT-53, a novel nanomedicine that crosses the BBB, augments immunotherapeutic response in pediatric brain cancers $295,104

Quick answers

Who received award HT94252310987?

HT94252310987 was awarded to Children's Research Institute by Defense Health Agency (Department of Defense) on August 31, 2023.

How much is award HT94252310987 worth?

$1,528,727 has been obligated on HT94252310987.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award